Scalable Xeno-Free Expansion of Mesenchymal Stem Cells in a Fixed-Bed Bioreactor
About
An exclusive on-demand webinar from Phacilitate in collaboration with Rooster Bio & Univercells Technologies
Explore the future of scalable, cost-effective mesenchymal stem cell (MSC) manufacturing. This webinar showcases a groundbreaking case study on the seamless transfer and expansion of MSCs using Rooster Bio’s xeno-free MSC platform in Univercells Technologies’ scale-X fixed-bed bioreactor. Learn how innovative bioprocess monitoring, optimized cell harvesting, and scalable expansion strategies are driving advancements in cell therapy manufacturing.
Key highlights include:
✔ Seamless process transfer from flask to bioreactor with Rooster Bio’s xeno-free media
✔ Predictive bioprocess monitoring using Skaia vision software
✔ Optimized cell harvesting with high viability (>96%)
✔ Scalable, cost-effective solutions for MSC expansion
Watch now to discover how this collaborative approach is accelerating therapeutic manufacturing.
Brought to you in collaboration with Univercells Technologies and Rooster Bio.
on-demand webinar
Presenter
Marcaurele Brun
Senior Manager, Planning at Sony Corporation, Japan